Zevra Therapeutics, Inc. (ZVRA)
9.23
-0.17
(-1.81%)
USD |
NASDAQ |
Mar 20, 16:00
9.24
+0.01
(+0.11%)
After-Hours: 20:00
Zevra Therapeutics Profit Margin (Quarterly) : 34.67% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Stereotaxis, Inc. | -64.00% |
| Ironwood Pharmaceuticals, Inc. | -4.77% |
| Verastem, Inc. | -187.7% |
| ADMA Biologics, Inc. | 35.48% |
| Myomo, Inc. | -33.59% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 85.33% |
| Return on Assets | 35.67% |
| Return on Invested Capital | 52.06% |
| Gross Profit Margin (Quarterly) | 94.48% |
| Operating Margin (Quarterly) | 27.30% |
| Return on Net Operating Assets | 148.5% |